UCB builds on re­la­tion­ship with Mi­crosoft with new AI deal; Sanofi part­ners with Ger­man AAV vec­tor biotech

More biotechs are jump­ing on the AI band­wag­on, and you can count UCB as one of them.

The Bel­gian com­pa­ny inked a “mul­ti-year” deal with Mi­crosoft on Tues­day, gain­ing ac­cess to its com­pu­ta­tion­al ser­vices, cloud and AI tech. The col­lab­o­ra­tion builds on work UCB did with Mi­crosoft through the COVID Moon­shot project, a crowd­sourced ini­tia­tive to ac­cel­er­ate the de­vel­op­ment of an­tivi­ral can­di­dates.

“It’s one of the ex­pe­ri­ences that built up to this part­ner­ship,” CIO Her­man De Prins said in an in­ter­view with End­points News. 

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

Venture & Research Associate

Alexandria Real Estate Equities

San Francisco, CA, USA